Jane Street Group, LLC Rubius Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$9.68 - $17.74 $145,200 - $266,100
-15,000 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$17.6 - $25.91 $448,800 - $660,705
-25,500 Reduced 62.96%
15,000 $268,000
Q2 2021

Aug 16, 2021
BUY
$22.26 - $28.43 $514,206 - $656,733
23,100 Added 132.76%
40,500 $989,000
Q1 2021

May 18, 2021
BUY
$8.02 - $32.01 $139,548 - $556,974
17,400 New
17,400 $461,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email